The largest database of trusted experimental protocols

7 protocols using nup98

1

Comprehensive Organelle Protein Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein was probed for pan-cadherin (4068), COX-IV (4850), NUP98 (2598), Atg5 (12994), Atg7 (8558), cleaved PARP (5625) from Cell Signaling, for CCTα (Pcyt1A, ab109263), ECT (Pcyt2, ab15053), calnexin (ab22595), calreticulin (ab2907), golgin-97 (ab84340), FAM134b (ab151755), collagen-IV (ab6586) from Abcam and for LC3B (0231-100) from Nanotools. β-Actin (4970), GAPDH (2118) and β-tubulin (2128) from Cell Signaling were used as loading control.
+ Open protocol
+ Expand
2

Comprehensive Protein Analysis in Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies and sources: CDK9 (1.1000), pCDK9 (Thr187) (1.1000), RNAPII (1.1000), phospho-RNAPII(Ser2) (1.1000), PARP (1.1000), and NUP98 (1.1000) (Cell Signaling Technology); HEXIM1 (1.1000), NELF-a (1.1000), LARP-7 (1.1000), c-Myc (1.1000), SPT5 (1.1000), and GAPDH (1.5000) (Santa Cruz Biotechnology, Dallas, TX, USA); BRD4 (1.1000) (Abcam, Waltham, MA, USA); Caspase-8 (1.1000) (Enzo Life Sciences, Farmingdale, NY, USA); β-Actin (1.10000), (Sigma-Aldrich, St. Louis, MO, USA); Cyclin T (1.1000) (Bethyl, Montgomery, TX, USA). Reagents and sources: CellTiter-Blue Cell Viability assay and Caspase-Glo 3/7 assays (Promega, Madison, WI, USA); AnnexinV and 7AAD (BD); BAY1251152, BI894999, ABBV744, Paclitaxel and Carboplatin (Selleckchem, Houston, TX, USA); BioCoat Matrigel invasion chamber (Corning, Corning, NY, USA); Migration chamber (Ibidi, Gräfelfing, Germany); RNeasy Plus kit (Qiagen, Venlo, The Netherlands). The following vectors were used: pCas9(BB)-2A-Puro (PX459) V2.0 (62988, Addgene, Watertown, MA, USA); p3xFlag-CMV-7.1 (E7533, Sigma, Ronkonkoma, NY, USA).
+ Open protocol
+ Expand
3

Molecular Interactions in SV40 System

Check if the same lab product or an alternative is used in the 5 most similar protocols
SV40 large T antigen (Santa Cruz sc-147), monoclonal VP1 was provided by Dr. Walter Scott (University of Miami), polyclonal VP1 (Abcam ab53977), SV40 VP2/3 (Abcam ab53983), RanBP2 (Thermo Scientific A301-796A), Nesprin-2 (Bethyl A305-393A, Thermo Scientific MA5-18075), Hsp90 (Santa Cruz sc-13119), GFP (Dawen Cai, University of Michigan), FLAG (Millipore Sigma F7425), MAB414 NPC (Abcam ab24609), Histone H3 (Cell Signaling 9715S), BAP31 (Pierce MA3-002), Rab7 (Millipore Sigma R8779), Na+/K+ ATPase (Abcam ab76020), LAMP2 (Abcam ab18529), NUP35 (Millipore Sigma HPA018410), NUP88 (Santa Cruz sc-365868), NUP93 (Thermo Scientific A303-979A), NUP98 (Cell Signaling 2598S), NUP133 (Santa Cruz sc-376763), and NUP188 (Thermo Scientific PA5-66645), BICD2 (Abcam (ab117818).
+ Open protocol
+ Expand
4

Comprehensive Protein Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies and sources: CDK9, pCDK9, RNAPII, phospho-RNAPII, TGM2, Cyclin B1, Cyclin E1, and NUP98 (Cell Signaling Technology); CDC37, SPT5, Stomatin, PLK1, Cyclin A1 (Santa Cruz Biotechnology); BRD4, Cyclin T1 and GFP (Abcam); Caspase-8 (Enzo Life Sciences); β-Actin, pCDK9, Vimentin, and Flag (Sigma-Aldrich).
Reagents and sources: CellTiter-Blue Cell Viability assay and Caspase-Glo 3/7 assay (Promega); BrdU kit (Roche); Thymidine, 5-ethynyl uridine (EU), Azide-fluor 488 (Sigma-Aldrich); AnnexinV and 7AAD (BD); [γ-32P] ATP (3000Ci/mmol, Amersham Pharmacia); Trail, FasL (Enzo Life Sciences); PLA assay kit (Olink Biosciences); BAY1251152, Cisplatin, and Carboplatin (Selleckchem); BioCoat Matrigel invasion chamber (Corning); Migration chamber (Ibidi); RNeasy Plus kit (Qiagen), active GST-CDK9/Cyclin K (SRP5012, Sigma-Aldrich).
The following vectors were used: pCas9(BB)-2A-Puro (PX459) V2.0 (62988, Addgene); p3xFlag-CMV-7.1 (E7533, Sigma); pGEX-5X-3 (28–9545-55, GE Healthcare) and pEGFP-C2 (6083-1, Clontech). All siRNAs and primers were from Sigma-Aldrich.
+ Open protocol
+ Expand
5

ChIP-seq analysis of chromatin-binding proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (40 × 106) were fixed in 1% paraformaldehyde (PFA) for 10 min, and ChIP-seq was performed as described previously (Liang et al. 2013 (link); Jacinto et al. 2015 (link)). The following antibodies were used for ChIP: Nup98 (purchased from Cell Signaling Technologies, P671, no.2292), H3K4me3 (purchased from Abcam, ab8580), Set1A (purchased from Abcam, ab70378), and Flag (purchased from Sigma, Flag M2 affinity gel, no. A2220). Reads were aligned to the mouse genome (mm10 and GRCm38) (Figs. 15) or human genome (hg19 and GRCh37) (Supplemental Fig. S4D) using bwa (version 0.7.12) (Li and Durbin 2009 (link)). Only reads that aligned uniquely to a single genomic location (MAPQ > 10) were used for downstream analysis. ChIP-seq peaks and normalized bedGraph files were generated using HOMER using a false discovery rate of 0.1% and fold enrichment over input of at least fourfold (Heinz et al. 2010 (link)). Data used to characterize binding of genomic elements by RUNX1 and HOXB4 (Fig. 1C) were obtained through Gene Expression Omnibus from Fan et al. (2012) (link) and Wu et al. (2012) (link).
+ Open protocol
+ Expand
6

Protein Analysis of ATM-Deficient Bone Marrow

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested from wild-type and ATM-null BM culture at indicated days, and then lysed in ice-cold lysis buffer (50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA (pH 8.0), 20 mM NaF, 1 mM Na3VO4, 1% NP40, 0.5 mM dithiothreitol) in the presence of protease–inhibitor mix (leupeptin, aprotinin, and PMSF, 10 μg/ml, respectively). Total cell lysate (10 μg) was loaded and separated by 6∼15% SDS-PAGE gels. Antibodies for ATM (GeneTex, Irvine, CA, USA), Akt, Erk, H2AX (Santa Cruz Biotechnology, Santa Cruz, CA, USA), p38, STAT5, NUP98, Histone H3, eIF4E, and 4EBP1 (Cell Signaling Technology, Danvers, MA, USA) were used to detect total proteins. Specific anti-phosphorylation antibodies were used against phosphor-H2AX (γH2AX, Novus Biologicals, Littleton, CO, USA), phospho-Akt (Ser473), phospho-p44/p42 (Thr202/Tyr204), phospho-p38 (Thr180/Try182), and phosphor-STAT5 (Tyr694, all from Cell signaling Technology). The antibody for phosphorylated mouse ATM (S1987) was purchased from R&D systems (Minneapolis, MN, USA). Specificities of ATM antibodies used in this study are shown in Supplementary Figure S3. Anti-actin antibody (Santa Cruz Biotechnology) was used to validate protein amount. To analyze the localization of ATM in BM, cytoplasmic extract and nuclear extract were prepared as described.50 (link)
+ Open protocol
+ Expand
7

Quantifying DNA Damage and Autophagy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were cultured in Lab‐Tek II 8‐well chamber slides, fixed with 4% PFA (10 min), permeabilized with 0.5% Triton X‐100 (5 min), then blocked and stained with antibodies against: dsDNA (Santa Cruz, 1:500), γH2AX, NUP98, pTBK1 (both Cell Signaling, 1:200), LC3 (Novus Biologicals, 1:200) or biotin‐LAMP1 (BioLegend, 1:200), followed by fluorescent secondary antibodies (45 min). Methanol fixation was used for anti‐pIRF3 (Cell Signaling, 1:200) staining.
Nuclear and cytosolic DNA signals from 5 of 10× or 20× images (~50–200 cells per image) were quantified using Fiji. Region of interest (ROI) was defined in each image and threshold set to measure fluorescence above background. Nuclear ROI was defined by DAPI staining and its intensity subtracted from total fluorescence to determine cytoplasmic signal. Quantitative fluorescence was presented as integrated density per cell with cell number determined by particle count of DAPI.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!